Cargando…

Reduction in expenditures on analgesics during one year of treatment of chronic tension headache with BoNT-A

The aim of this study was to investigate the impact of the use of botulinum toxin type A (BoNT-A; BOTOX; Allergan, Inc.; Irvine, CA) as preventive treatment of chronic tension-type headache (CTH) on analgesic use and expenditure. This was a prospective, single-center, 1-year, open-label study of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coloprisco, Gabriella, De Filippis, Sergio, Santi, Pier Giorgio, Fiore, Giuseppe, Rodio, Anna, Martelletti, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2003
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452140/ http://dx.doi.org/10.1007/s10194-003-0037-6

Ejemplares similares

Navigating the Complexities Involving the Identification of Botulinum Neurotoxins (BoNTs) and the Taxonomy of BoNT-Producing Clostridia
por: Smith, Theresa J., et al.
Publicado: (2023)

Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience
por: Farinelli, I., et al.
Publicado: (2006)

Mucosal Targeting of a BoNT/A Subunit Vaccine Adjuvanted with a Mast Cell Activator Enhances Induction of BoNT/A Neutralizing Antibodies in Rabbits
por: Staats, Herman F., et al.
Publicado: (2011)

Aspirin and tension-type headache
por: Farinelli, I., et al.
Publicado: (2007)

The Effects of Intradetrusor BoNT-A Injections on Vesicoureteral Reflux in Children With Myelodysplasia
por: Toprak, Tuncay, et al.
Publicado: (2019)

Exploring the genetic background of the botulism neurotoxin BoNT/B2 in Spain
por: Valdezate, Sylvia, et al.
Publicado: (2023)

Analgesic therapy for headache: consumption, appropriateness and costs
por: Iannazzo, Stefania, et al.
Publicado: (2003)

BoNT/A in the Urinary Bladder—More to the Story than Silencing of Cholinergic Nerves
por: Ibrahim, Hodan, et al.
Publicado: (2022)

A novel RRGW derived peptide is a promising inhibitor of BoNT/A
por: Ma, Wantong, et al.
Publicado: (2023)

Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches
por: Martinelli, Daniele, et al.
Publicado: (2023)

Small-Molecule Quinolinol Inhibitor Identified Provides Protection against BoNT/A in Mice
por: Singh, Padma, et al.
Publicado: (2012)

Probing BoNT/A Protease Exosites: Implications for Inhibitor Design and Light Chain Longevity
por: Xue, Song, et al.
Publicado: (2014)

Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT)
por: Bai, Lili, et al.
Publicado: (2018)

Botulinum neurotoxin (BoNT) treatment in functional movement disorders: long-term follow-up
por: Dreissen, Yasmine EM, et al.
Publicado: (2020)

A Three-Monoclonal Antibody Combination Potently Neutralizes BoNT/G Toxin in Mice
por: Fan, Yongfeng, et al.
Publicado: (2023)

Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism
por: Webb, Robert P., et al.
Publicado: (2017)

Hypersensitive Detection and Quantitation of BoNT/A by IgY Antibody against Substrate Linear-Peptide
por: Li, Tao, et al.
Publicado: (2013)

Retraction: Small-Molecule Quinolinol Inhibitor Identified Provides Protection against BoNT/A in Mice
por: Singh, Padma, et al.
Publicado: (2013)

Designing and analyzing the structure of Tat-BoNT/A(1-448) fusion protein: An in silico approach
por: Amani, Jafar, et al.
Publicado: (2014)

The Novel Clostridial Neurotoxin Produced by Strain IBCA10-7060 Is Immunologically Equivalent to BoNT/HA
por: Fan, Yongfeng, et al.
Publicado: (2019)

Plasma Levels of Oxidative Stress Markers, before and after BoNT/A Treatment, in Chronic Migraine
por: Dini, Elisa, et al.
Publicado: (2019)

Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve Injury
por: Adler, Michael, et al.
Publicado: (2022)

Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine
por: Lou, Jianlong, et al.
Publicado: (2018)

Effect of BoNT/A in the Surface Electromyographic Characteristics of the Pelvic Floor Muscles for the Treatment of Chronic Pelvic Pain
por: Albaladejo-Belmonte, Monica, et al.
Publicado: (2021)

BoNT/A1 Secondary Failure for the Treatment of Neurogenic Detrusor Overactivity: An Ex Vivo Functional Study
por: Maignel, Jacquie, et al.
Publicado: (2022)

Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals?
por: Baricich, Alessio, et al.
Publicado: (2023)

The Efficacy of Transvaginal Ultrasound-Guided BoNT-A External Sphincter Injection in Female Patients with Underactive Bladder
por: Tsai, Cheng-Yen, et al.
Publicado: (2023)

Headache and mood disorders
por: De Filippis, S., et al.
Publicado: (2005)

Salivary cortisol, dehydroepiandrosteronesulphate (DHEA–S) and testosterone in women with chronic migraine
por: Patacchioli, F. R., et al.
Publicado: (2006)

Further optimization of peptide substrate enhanced assay performance for BoNT/A detection by MALDI-TOF mass spectrometry
por: Wang, Dongxia, et al.
Publicado: (2017)

Human-Relevant Sensitivity of iPSC-Derived Human Motor Neurons to BoNT/A1 and B1
por: Schenke, Maren, et al.
Publicado: (2021)

BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel Approach
por: Baricich, Alessio, et al.
Publicado: (2021)

Subcutaneous BoNT/A Injection for Intractable Pain and Disability in Complex Regional Pain Syndrome: A Case Report
por: Tereshko, Yan, et al.
Publicado: (2022)

Comparison of botulinum toxin (BoNT) injection and lateral internal sphincterotomy (redo-LIS) for recurrent anal fissure treatment
por: Alyanak, Ahmet, et al.
Publicado: (2022)

Multicolor fluorescence activated cell sorting to generate humanized monoclonal antibody binding seven subtypes of BoNT/F
por: Fan, Yongfeng, et al.
Publicado: (2022)

Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis
por: Cinone, Nicoletta, et al.
Publicado: (2022)

Outbreaks of iatrogenic botulism in Europe: Combating off-label medical use of Botulinum Neurotoxin (BoNT) in bariatric procedures
por: Jain, Nityanand, et al.
Publicado: (2023)

A one-year retrospective economic evaluation of botulinum toxin type A treatment of chronic tension headache
por: Mennini, Francesco S., et al.
Publicado: (2004)

A one-year prospective costing study of botulinum toxin type A treatment of chronic tension headache
por: Palazzo, Fabio, et al.
Publicado: (2004)

Alpha-Latrotoxin Rescues SNAP-25 from BoNT/A-Mediated Proteolysis in Embryonic Stem Cell-Derived Neurons
por: Mesngon, Mariano, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_i2vji7dntci3bnvafkibmrn6kg